-
Professor Yongsheng Wang: What Has Changed—and What Remains—in Breast Cancer Surgery?
Breast cancer has recently surpassed lung cancer as the most commonly diagnosed cancer among women worldwide. The status of regional lymph node involvement remains a key prognostic factor, directly influencing disease staging, treatment planning, and survival outcomes. While axillary lymph node dissection (ALND) has long been the standard for staging, it carries substantial morbidity. As…
-
2026 CASH | Science Knows No Borders, Cooperation Shapes the Future: A Dialogue with International Forum Chair Professor Toshio Suda
As a new year begins, global leaders in hematology gathered in Tianjin from January 9–11, 2026, for the 6th China Hematology Discipline Development Conference (CASH). This year’s congress introduced its first-ever International Forum, establishing a new bridge for in-depth dialogue between Chinese and global hematology communities. As one of the Forum Chairs, Professor Toshio Suda…
-
Lymphoma Frontline Advances | Professor Qingqing Cai: Breakthrough Progress in First-Line Bispecific Antibody Therapy for Lymphoma — ASH 2025 Special
The 2025 American Society of Hematology (ASH) Annual Meeting recently concluded in Orlando, USA, showcasing major breakthroughs in lymphoma research and offering new directions for optimizing clinical care. To translate cutting-edge science into clinical insight, Oncology Frontier – Hematology Frontier partners with Professor Qingqing Cai of Sun Yat-sen University Cancer Center to present the “Lymphoma…
-
CASH 2026 | Professor Zhigang Cai: Breakthrough Advances in Clonal Hematopoiesis, MDS, MPN, and VEXAS Syndrome
From January 9–11, 2026, the 6th China Hematology Discipline Development Conference (CASH) was successfully held in Tianjin. The meeting brought together leading international and national experts in hematology, focusing on frontier scientific advances and national health priorities, fostering deep academic exchange and shaping future directions of the discipline.
-
CASH 2026 | Professor Jian Li: Peking Union Medical College Hospital’s Experience in the Diagnosis and Treatment of AL Amyloidosis
As the new year begins, leading experts gathered in Tianjin. From January 9–11, 2026, the 6th China Hematology Discipline Development Conference (CASH) was successfully held, bringing together top hematology specialists from China and abroad. The conference focused on cutting-edge scientific progress and national health priorities, fostering in-depth discussions on the future of hematology.
-
CASH 2026 | Academician Tao Cheng: From “Hematologic Ecology” to a “Greater Hematology” Vision—Charting a New Blueprint for Hematology in China’s 15th Five-Year Plan
From January 9 to 11, 2026, the 6th China Hematology Discipline Development Conference (CASH) was held in Tianjin. Coinciding with the launch of China’s 15th Five-Year Plan, the conference centered on the theme “Tianjin: Renewing Momentum, Intelligence Leading the Future.” With a forward-looking perspective, the meeting focused on the systemic evolution and ecological integration of…
-
How to Develop Personalized Bladder-Preserving Strategies for MIBC? Professor Yijun Shen Shares MDT Experience and Clinical Decision Pathways
From January 10 to 11, 2026, the Beijing Young Urologic Oncology Physicians Academic Exchange Conference was successfully held in Beijing. The meeting brought together leading experts and young physicians in urologic oncology to discuss cutting-edge scientific advances and real-world clinical challenges, with the goal of fostering academic innovation and supporting the development of young clinicians.
Connecting Medical Expertise through Media
